2026 · 3rd Quarter (July 1 - Sep 30)

AMGEN

Filed by ALPINE GROUP PARTNERS, LLC..

Open official filing

Source-reported fields

Filing overview

Type: 3rd Quarter - Report
Posted: Oct 15, 2026
Income: $50,000.00
Expenses: Not reported
Registrant: ALPINE GROUP PARTNERS, LLC.
Client: AMGEN
Filing UUID: d00b9d65-0494-4649-8996-09105d213d33
Termination date: Not reported

Literal source text

Lobbying issues and bill citations

MMM · Medicare/Medicaid

Proposals related to drug pricing, drug price transparency, PBMs, the 340B program Implementation of the Inflation Reduction Act

TAX · Taxation/Internal Revenue Code

International tax developments

TRD · Trade (domestic/foreign)

Tariffs

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.